Solberg Barbara C J, Dirksen Carmen D, Nieman Fred H M, van Merode Godefridus, Poeze Martijn, Ramsay Graham
Staff Department of Research, Care and Education, Maastricht University Hospital, P. Debyelaan 25 6229 HX Maastricht, The Netherlands.
Crit Care. 2008;12(3):R68. doi: 10.1186/cc6903. Epub 2008 May 15.
The high cost of critical care resources has resulted in strategies to reduce the costs of ruling out low-risk patients by developing intermediate care units (IMCs). The aim of this study was to compare changes in total hospital costs for intensive care patients before and after the introduction of an IMC at the University Hospital Maastricht.
The design was a comparative longitudinal study. The setting was a university hospital with a mixed intensive care unit (ICU), an IMC, and general wards. Changes in total hospital costs were measured for patients who were admitted to the ICU before and after the introduction of the IMC. The comparison of interest was the opening of a six-bed mixed IMC.
The mean total hospital cost per patient increased significantly. Before the introduction of the IMC, the total hospital cost per patient was n12,961 (+/- n14,530) and afterwards it rose to n16,513 (+/- n17,718). Multiple regression analysis was used to determine to what extent patient characteristics explained these higher hospital costs using mortality, type of stay, diagnostic categories, length of ICU and ward stay, and the Therapeutic Intervention Scoring System (TISS) as predictors. More surgical patients, greater requirements of therapeutic interventions on the ICU admission day, and longer ICU stay in patients did explain the increase in hospital costs, rather than the introduction of the IMC.
After the introduction of the IMC, the higher mean total hospital costs for patients with a high TISS score and longer ICU stay explained the cost increase.
重症监护资源成本高昂,因此人们制定了相关策略,通过设立中间护理单元(IMC)来降低排除低风险患者的成本。本研究旨在比较马斯特里赫特大学医院引入IMC前后重症监护患者的总住院费用变化。
采用比较纵向研究设计。研究地点为一家设有混合重症监护病房(ICU)、IMC和普通病房的大学医院。对引入IMC前后入住ICU的患者的总住院费用变化进行了测量。感兴趣的比较对象是一个六床位混合IMC的启用。
每位患者的平均总住院费用显著增加。引入IMC之前,每位患者的总住院费用为12,961欧元(±14,530欧元),之后升至16,513欧元(±17,718欧元)。使用死亡率、住院类型、诊断类别、ICU和病房住院时长以及治疗干预评分系统(TISS)作为预测因素,采用多元回归分析来确定患者特征在多大程度上解释了这些较高的住院费用。更多的外科手术患者、入住ICU当天对治疗干预的更高需求以及患者更长的ICU住院时间确实解释了住院费用的增加,而非IMC的引入。
引入IMC后,TISS评分高且ICU住院时间长的患者平均总住院费用较高,这解释了费用的增加。